Medivault
Mark Jackson is an accomplished executive with extensive experience in leadership roles across various sectors, including healthcare, technology, and finance. Currently serving as Chief Executive Officer at Medivault since April 2023, Jackson is instrumental in advancing the company's transition towards Health 3.0. Prior to this, Jackson held positions such as Director at Medicabis, where strategic development focused on all-natural therapeutics, and CEO & President at Lifelines Neuro, overseeing a successful 80-person med-tech operation. Additional experience includes advisory roles and senior leadership at Thomson Reuters, where Jackson drove significant growth initiatives across multiple global markets. Educational qualifications include attendance at MEDDIC Academy and West Herts College, complemented by a background in performing arts from The Barrow Group Performing Arts Center.
This person is not in any teams
Medivault
At Medivault, we’re leading the shift from Health 2.0 to Health 3.0 with our innovative clinical health and wellness platform. By consolidating fragmented patient data, we provide real-time, actionable insights that empower individuals, and their care teams, to prevent illness before it starts. Our AI-driven predictive risk scores and personalised health recommendations help people make smarter lifestyle choices, proactively manage their health, and reduce disease risks. This isn’t just about treatment—it’s about prevention, promoting longevity and an improved health-span. Join us in transforming healthcare to be proactive, personalised, and focused on long-term wellness!